Co-Diagnostics, Inc. (LON: 0A50)
London
· Delayed Price · Currency is GBP · Price in USD
0.794
-0.001 (-0.09%)
At close: Jan 22, 2025
Co-Diagnostics Market Cap
Co-Diagnostics has a market cap or net worth of 21.52 million as of January 23, 2025. Its market cap has decreased by -31.05% in one year.
Market Cap
21.52M
Enterprise Value
-7.14M
Revenue
5.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.79
Market Cap Chart
Since July 12, 2017, Co-Diagnostics's market cap has decreased from 53.76M to 21.52M, a decrease of -59.98%. That is a compound annual growth rate of -11.44%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 171.37B |
Shell | 167.06B |
HSBC Holdings | 145.32B |
Unilever | 114.25B |
Rio Tinto Group | 85.64B |
RELX PLC | 74.08B |
BP p.l.c. | 67.32B |
British American Tobacco p.l.c. | 65.03B |